Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3399-3419

  Bennet, Devasier ^a   Marimuthu, Mohana ^a   Kim, Sanghyo ^a   An, Jeongho ^b  

^a Gachon University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Biocompatible materials; Encapsulation; Quercetin; Transdermal; Voglibose

Indexed keywords

MOLECULAR SCAFFOLD; NANOPARTICLE; OLEIC ACID; POLYGLACTIN; QUERCETIN; VOGLIBOSE;

ADULT; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CELL ADHESION; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; EX VIVO STUDY; EXCIPIENT COMPATIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGHT SCATTERING; MALE; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; WATER ABSORPTION;

ADULT; BIOCOMPATIBLE MATERIALS; CELL LINE; DELAYED-ACTION PREPARATIONS; FIBROBLASTS; HUMANS; HYDROGEN-ION CONCENTRATION; INOSITOL; LACTIC ACID; MALE; NANOPARTICLES; NANOSTRUCTURES; OLEIC ACID; PARTICLE SIZE; POLYGLYCOLIC ACID; QUERCETIN; SKIN ABSORPTION; TEMPERATURE;

EID: 84870381657     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32800     Document Type: Article

References (55)

1. Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vasc Health Risk Manag. 2005;1(1):55-71.
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84(4):1381-1477.
3. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol. 2005;4(1):1475-2840.
4. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24-38.
5. Nichols JA, Katiyar SK. Skin photoprotection by natural polyphenols: anti-inflammatory, anti-oxidant and DNA repair mechanisms. Arch Dermatol Res. 2010;302(2):71-83.
6. Bonina F, Lanza M, Montenegro L, etal. Flavonoids as potential protective agents against photo-oxidative skin damage. Int J Pharm. 1996;145(1-2):87-94.
7. Esposito K, Nappo F, Marfella R, etal. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans role of oxidative stress. Circulation. 2002;106(16):2067-2072.
8. Esposito K, Marfella R, Giugliano D. Stress hyperglycemia, inflammation, and cardiovascular events. Diabetes Care. 2003;26(5):1650-1651.
9. Heimberg H, Heremans Y, Jobin C, etal. Inhibition of cytokine-induced NF-kB activation by adenovirus-mediated expression of a NF-kB super-repressor prevents β-cell apoptosis. Diabetes. 2001; 50(10):2219-2224.
10. Lin HJ, Lu AY. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev. 1997;49(4):403-449.
11. Satoh N, Shimatsu A, Yamada K, etal. An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1in obese type 2 diabetic patients. Metabolism. 2006;55(6):786-793.
12. Yan S, Xiaoqiang L, Shuiping L, Xiumei M, Ramakrishna S. Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids Surf B Biointerfaces. 2009;73(2):376-381.
13. Xu J, Jiao Y, Shao X, Zhou C. Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly(L-lactic acid) fiber mats loaded with chitosan microspheres. Mater Lett. 2011;65(17-18):2800-2803.
14. Li YQ, Zhou FC, Gao F, Bian JS, Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem. 2009;57(24):11463-11468.
15. Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 2010; 4(11):6303-6317.
16. Guzik TJ, Mussa S, Gastaldi D, etal. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656-1662.
17. Ju-Ichi M. Chemical study of citrus plants in the search for cancer chemopreventive agents. Yakugaka Zasshi. 2005;125(3):231-254. Japanese.
18. Kolishetti N, Dhar S, Valencia PM, etal. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A. 2010;107(42):17939-17944.
19. Tang DW, Yu S, Ho YC, Mi FL, Kuo PL, Sung HW. Heparinized chitosan/poly(-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials. 2010;31(35):9320-9332.
20. Misra R, Sahoo SK. Co-formulation of doxorubicin and curcumin in poly(D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm. 2011; 8(3):852-866.
21. Song XR, Cai Z, Zheng Y, etal. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci. 2009;37(3-4):300-305.
22. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011;9(1):55.
23. Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm. 2005;289(1-2):167-178.
24. Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm. 2005;288(2):227-233.
25. Yerramsetty KM, Rachakonda VK, Neely BJ, Madihally SV, Gasem KAM. Effect of different enhancers on the transdermal permeation of insulin analog. Int J Pharm. 2010;398(1-2):83-92.
26. Vaddi HK, Ho PC, Chan YW, Chan SY. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J Control Release. 2002;81(1-2):121-133.
27. Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev. 2004;104(12):6017-6084.
28. Subbiah R, Veerapandian M, Yun KS. Nanoparticles: functionalization and multifunctional applications in biomedical sciences. Curr Med Chem. 2010;17(36):4559-4577.
29. Srinivasa PC, Ramesh MN, Tharanathan RN. Effect of plasticizers and fatty acids on mechanical and permeability characteristics of chitosan films. Food Hydrocolloid. 2007;21(7):1113-1122.
30. Zhang ML, Gong XH, Zhao YD, Zhang NM. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials. 2002;23(13):2641-2648.
31. Badet C, Furiga A, Thebaud N. Effect of xylitol on an in vitro model of oral biofilm. Oral Health Prev Dent. 2008;6(4):337-341.
32. Chandy T, Mooradian DL, Rao GH. Chitosan/polyethylene glycol-alginate microcapsules for oral delivery of hirudin. J Appl Polym Sci. 1998;70(11):2143-2153.
33. Rajangam T, Paik HJ, An SSA. Development of fibrinogen microspheres as a biodegradable carrier for tissue engineering. Bio Chip J. 2011;5(2):175-183.
34. Bromberg LE, Ron ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev. 1998;31(3):197-221.
35. Jain GK, Sharma AK, Agrawal SS. Transdermal controlled administration of verapamil-enhancement of skin permeability. Int J Pharm. 1996;130(2):169-177.
36. Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretinoin-loaded nanocapsules: preparation, physicochemical characterization and photostability study. Int J Pharm. 2008;352(1-2):1-4.
37. Liong M, Lu J, Kovochich M, etal. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008;2(5):889-896.
38. Comelles F, Sanchez-Leal J, Gonzalez JJ. Soybean oil microemulsions with oleic acid/glycols as cosurfactants. J Surfactants Deterg. 2005;8(3):257-262.
39. Kumari A, Yadav SK, Pakade YB, Singh B, Yadav SC. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf B Biointerfaces. 2010;80(2):184-192.
40. Comelles F, Sanchez-Leal J, Gonzalez JJ. Influence of ionic surfactants on the formation of liquid crystals in oleic acid/glycol/water systems. J Surfactants Deterg. 2007;10(3):137-144.
41. Dhana LUM, Poovi G, Kishore N, Reddy PN. In-vitro characterization and in-vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles. Int J Pharm. 2010;396(1-2):194-203.
42. Mallikarjuna RN, Bagyalakshmi J, Ravi TK. Development and validation of UV-spectroscopic method for estimation of voglibose in bulk and tablets. J Chem Pharm Res. 2010;2(2):350-356.
43. Guo R, Du X, Zhang R, Deng L, Dong A, Zhang J. Bioadhesive film formed from a novel organic-inorganic hybrid gel for transdermal drug delivery system. Eur J Pharm Biopharm. 2011;79(3):574-583.
44. Cui F, He C, Yin L, etal. Nanoparticles incorporated in bilaminated films: a smart drug delivery system for oral formulations. Biomacromolecules. 2007;8(9):2845-2850.
45. Adhirajan N, Shanmugasundaram N, Babu M. Gelatin microspheres crosslinked with EDC as a drug delivery system for doxycycline: development and characterization. J Microencapsul. 2007;24(7):659-671.
46. Marimuthu M, Kim S, An J. Amphiphilic triblock copolymer and a microfluidic device for porous microfiber fabrication. Soft Matter. 2010;6(10):2200-2207.
47. Kumar TR, Shanmugasundaram N, Babu M. Biocompatible collagen scaffolds from a human amniotic membrane: physiochemical and in vitro culture characteristics. J Biomater Sci Polym Ed. 2003; 14(7):689-706.
48. Aryal S, Hu CM, Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm. 2011;8(4):1401-1407.
49. Bennet D, Kim S. A transdermal delivery system to enhance quercetin nanoparticle permeability. J Biomater Sci Polym E. (In press).
50. Gupta NV, Gowda DV, Balamuralidhara V, Mohammed Khan S. Formulation and evaluation of olanzapine matrix pellets for controlled release. DARU J Pharm Sci. 2011;19(4):249-256.
51. Fredin NJ, Zhang JT, Lynn DM. Surface analysis of erodible multilayered polyelectrolyte films: Nanometer-scale structure and erosion profiles. Langmuir. 2005;21(13):5803-5811.
52. Schild HG. Poly(N-isopropylacrylamide): experiment, theory and application. Prog Polym Sci. 1992;17(2):163-249.
53. Zhang J, Deng L, Zhao H, etal. Pressure-sensitive adhesive properties of poly(N-vinyl pyrrolidone)/D, L-lactic acid oligomer/glycerol/water blends for TDDS. J Biomater Sci Polym Ed. 2010;21(1):1-15.
54. Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak-Kohn B. Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J Control Release. 2011;149(2):159-167.
55. Tan Q, Liu W, Guo C, Zhai G. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomedicine. 2011;6:1621-1630.